Cardiovascular Outcomes In Non-small Cell Lung Cancer With And Without Pembrolizumab: A Multi-center Retrospective Study
Fields of Study & Subjects
Chemotherapy-induced cardiotoxicity and mitigation
Cancer Immunotherapy and Biomarkers
Lung Cancer Diagnosis and Treatment
Publication details
- Journal / source
- Journal of Cardiac Failure
- Volume
- 32
- Issue
- 1
- Pages
- 210–210
- Publication date
- 1 January 2026
- Language
- EN